| Trial ID: | L3486 |
| Source ID: | NCT01018602
|
| Associated Drug: |
Vildagliptin
|
| Title: |
PINGUIN (Postpartum Intervention in Women With Gestational Diabetes Using Insulin)
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Insulin-dependent Gestational Diabetes
|
| Interventions: |
DRUG: vildagliptin|DRUG: inactive pill
|
| Outcome Measures: |
Primary: development of type 2 diabetes mellitus by criteria of ADA 1997, 3 years |
|
| Sponsor/Collaborators: |
Sponsor: Institut fur Diabetesforschung, Munich, Germany
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
140
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-01
|
| Completion Date: |
2015-06
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-27
|
| Locations: |
Institut fuer Diabetesforschung, Munich, 80804, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01018602
|
